Advertisement

Thrombolytic and Endovascular Therapies for Acute Ischemic Stroke

  • Hormozd Bozorgchami
  • Helmi L. Lutsep
Chapter
Part of the Springer Series in Translational Stroke Research book series (SSTSR)

Abstract

Although clinical trials have investigated thrombolytic therapies such as streptokinase, urokinase, and desmoteplase in acute ischemic stroke treatment, only trials assessing intravenous (IV) tissue plasminogen activator (tPA) and intraarterial prourokinase were successful in showing efficacy. Since a confirmatory trial with prourokinase was not performed, it has not been approved for treatment and IV tPA remains the standard of care. Advances in fluoroscopic imaging led to additional research in endovascular therapies as performing interventional cerebrovascular procedures became more feasible. After years of device development, enhanced acute stroke imaging, and improvements in systems of care, endovascular therapy has now shown efficacy in acute stroke treatment in randomized trials as well. Trials have shown the efficacy of stent retrievers compared to medical therapy alone in patients with anterior circulation large vessel occlusions. This has resulted in a paradigm shift in the management of acute ischemic stroke.

Keywords

Ischemic stroke Thrombolysis Thrombolytic Embolectomy Thrombectomy Stent retriever Stentriever Reperfusion tPA Solitaire Trevo Alteplase 

References

  1. 1.
    The Multicenter Acute Stroke Trial–Europe Study Group (1996) Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 335(3):145–150CrossRefGoogle Scholar
  2. 2.
    Multicentre Acute Stroke Trial—Italy (MAST-I) Group (1995) Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 346(8989):1509–1514CrossRefGoogle Scholar
  3. 3.
    Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ et al (1996) Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA 276(12):961–966CrossRefPubMedGoogle Scholar
  4. 4.
    Fletcher AP, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks JE et al (1976) A pilot study of urokinase therapy in cerebral infarction. Stroke 7(2):135–142CrossRefPubMedGoogle Scholar
  5. 5.
    Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S et al (2007) Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 38(10):2633–2639CrossRefPubMedGoogle Scholar
  6. 6.
    Furlan AHR, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282(21):2003–2011CrossRefPubMedGoogle Scholar
  7. 7.
    Albers GW, von Kummer R, Truelsen T, Jensen JK, Ravn GM, Gronning BA et al (2015) Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet Neurol 14(6):575–584CrossRefPubMedGoogle Scholar
  8. 8.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1587CrossRefGoogle Scholar
  9. 9.
    Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283(9):1145–1150CrossRefPubMedGoogle Scholar
  10. 10.
    Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W et al (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369(9558):275–282CrossRefPubMedGoogle Scholar
  11. 11.
    Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274(13):1017–1025CrossRefPubMedGoogle Scholar
  12. 12.
    Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352(9136):1245–1251CrossRefPubMedGoogle Scholar
  13. 13.
    Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282(21):2019–2026CrossRefPubMedGoogle Scholar
  14. 14.
    Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP et al (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363(9411):768–774CrossRefPubMedGoogle Scholar
  15. 15.
    Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K et al (2008) Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372(9646):1303–1309CrossRefPubMedGoogle Scholar
  16. 16.
    Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329CrossRefPubMedGoogle Scholar
  17. 17.
    Saver JL, Gornbein J, Grotta J, Liebeskind D, Lutsep H, Schwamm L et al (2009) Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke 40(7):2433–2437CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Clark WM, Madden KP (2009) Keep the three hour TPA window: the lost study of Atlantis. J Stroke Cerebrovasc Dis 18(1):78–79CrossRefPubMedGoogle Scholar
  19. 19.
    Alper BS, Malone-Moses M, McLellan JS, Prasad K, Manheimer E (2015) Thrombolysis in acute ischaemic stroke: time for a rethink? BMJ 350:h1075CrossRefPubMedGoogle Scholar
  20. 20.
    Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R et al (2010) Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol 9(9):866–874CrossRefPubMedGoogle Scholar
  21. 21.
    Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(3):870–947CrossRefPubMedGoogle Scholar
  22. 22.
    Group ISTc, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G et al (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379(9834):2352–2363CrossRefGoogle Scholar
  23. 23.
    Ingall TJ, O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA et al (2004) Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke 35(10):2418–2424CrossRefPubMedGoogle Scholar
  24. 24.
    Tong DC (2012) Avoiding thrombolysis in patients with mild stroke: is it SMART? Stroke 43(3):625–626CrossRefPubMedGoogle Scholar
  25. 25.
    Tissue Plasminogen Activator prescribing information [cited 2016 March 16, 2016]. http://www.gene.com/download/pdf/activase_prescribing.pdf.
  26. 26.
    A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS) [updated March 1, 2016; cited 2016 March 16, 2016]. https://clinicaltrials.gov/ct2/show/NCT02072226?term=prisms+and+stroke&rank=5.
  27. 27.
    Kent DM, Price LL, Ringleb P, Hill MD, Selker HP (2005) Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 36(1):62–65CrossRefPubMedGoogle Scholar
  28. 28.
    Lorenzano S, Ahmed N, Falcou A, Mikulik R, Tatlisumak T, Roffe C et al (2013) Does sex influence the response to intravenous thrombolysis in ischemic stroke?: answers from safe implementation of treatments in Stroke-International Stroke Thrombolysis Register. Stroke 44(12):3401–3406CrossRefPubMedGoogle Scholar
  29. 29.
    Rohan V, Baxa J, Tupy R, Cerna L, Sevcik P, Friesl M et al (2014) Length of occlusion predicts recanalization and outcome after intravenous thrombolysis in middle cerebral artery stroke. Stroke 45(7):2010–2017CrossRefPubMedGoogle Scholar
  30. 30.
    Schellinger PD, Alexandrov AV, Barreto AD, Demchuk AM, Tsivgoulis G, Kohrmann M et al (2015) Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial. Int J Stroke 10(7):1141–1148CrossRefPubMedGoogle Scholar
  31. 31.
    Acute and Preventive Stroke Treatments: American Stroke Association; 2016 [March 3, 2016]. http://www.strokeassociation.org/STROKEORG/AboutStroke/Treatment/Treatment_UCM_310892_Article.jsp.
  32. 32.
    Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O (2011) The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 42(6):1775–1777CrossRefPubMedGoogle Scholar
  33. 33.
    Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ (1988) intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19(10):1216–1222CrossRefPubMedGoogle Scholar
  34. 34.
    Fields JD, Khatri P, Nesbit GM, Liu KC, Barnwell SL, Lutsep HL et al (2011) Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion. J Neurointerv Surg 3(2):151–155CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG et al (2012) Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. The Lancet 380(9849):1241–1249CrossRefGoogle Scholar
  36. 36.
    Chopko BW, Kerber C, Wong W, Georgy B (2000) Transcatheter snare removal of acute middle cerebral artery thromboembolism: technical case report. Neurosurgery 46(6):1529–1531CrossRefPubMedGoogle Scholar
  37. 37.
    Sharafuddin MJ, Hicks ME, Jenson ML, Morris JE, Drasler WJ, Wilson GJ (1997) Rheolytic thrombectomy with use of the AngioJet-F105 catheter: preclinical evaluation of safety. J Vasc Interv Radiol 8(6):939–945CrossRefPubMedGoogle Scholar
  38. 38.
    Grundfest WS, Litvack F, Forrester JS, Goldenberg T, Swan HJ, Morgenstern L et al (1985) Laser ablation of human atherosclerotic plaque without adjacent tissue injury. J Am Coll Cardiol 5(4):929–933CrossRefPubMedGoogle Scholar
  39. 39.
    Grundfest WS, Litvack IF, Goldenberg T, Sherman T, Morgenstern L, Carroll R et al (1985) Pulsed ultraviolet lasers and the potential for safe laser angioplasty. Am J Surg 150(2):220–226CrossRefPubMedGoogle Scholar
  40. 40.
    MERCI Story [Webpage]. UC Regents; 2012 [cited 2016 February 28, 2016]. http://www.radnet.ucla.edu/radweb/sections/endovascular/news/MERCI_Story.jsp.
  41. 41.
    Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP et al (2005) Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36(7):1432–1438CrossRefPubMedGoogle Scholar
  42. 42.
    Alshekhlee A, Pandya DJ, English J, Zaidat OO, Mueller N, Gupta R et al (2012) Merci mechanical thrombectomy retriever for acute ischemic stroke therapy: literature review. Neurology 79(13 Suppl 1):S126–S134CrossRefPubMedGoogle Scholar
  43. 43.
    Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS et al (2008) Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39(4):1205–1212CrossRefPubMedGoogle Scholar
  44. 44.
    Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS (2009) Merci, et al. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 40(12):3777–3783CrossRefPubMedGoogle Scholar
  45. 45.
    Penumbra Pivotal Stroke Trial I (2009) The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40(8):2761–2768CrossRefGoogle Scholar
  46. 46.
    Saver JL, Liebeskind DS, Nogueira RG, Jahan R (2010) Need to clarify Thrombolysis In Myocardial Ischemia (TIMI) scale scoring method in the Penumbra Pivotal Stroke Trial. Stroke 41(2):e115–e116CrossRefPubMedGoogle Scholar
  47. 47.
    Mahon BR, Nesbit GM, Barnwell SL, Clark W, Marotta TR, Weill A et al (2003) North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 24(3):534–538PubMedGoogle Scholar
  48. 48.
    Tomsick T, Broderick J, Carrozella J, Khatri P, Hill M, Palesch Y et al (2008) Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 29(3):582–587CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Goyal M, Fargen KM, Turk AS, Mocco J, Liebeskind DS, Frei D et al (2014) 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointerv Surg 6(2):83–86CrossRefPubMedGoogle Scholar
  50. 50.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J et al (2003) Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34(8):e109–e137CrossRefPubMedGoogle Scholar
  51. 51.
    Kulcsar Z, Bonvin C, Lovblad KO, Gory B, Yilmaz H, Sztajzel R et al (2010) Use of the enterprise intracranial stent for revascularization of large vessel occlusions in acute stroke. Clin Neuroradiol 20(1):54–60CrossRefPubMedGoogle Scholar
  52. 52.
    Suh SH, Lee KY, Seo KD, Lim SM, Roh HG, Kim BM (2013) Recanalization of acute intracranial artery occlusion using temporary endovascular bypass technique. Neurointervention 8(2):80–86CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA et al (2012) Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. The Lancet 380(9849):1231–1240CrossRefGoogle Scholar
  54. 54.
    Zaidat OO, Castonguay AC, Gupta R, Sun CH, Martin C, Holloway WE et al (2014) North American Solitaire Stent Retriever Acute Stroke registry: post-marketing revascularization and clinical outcome results. J Neurointerv Surg 6(8):584–588CrossRefPubMedGoogle Scholar
  55. 55.
    Campbell BC, Hill MD, Rubiera M, Menon BK, Demchuk A, Donnan GA et al (2016) Safety and Efficacy of Solitaire Stent Thrombectomy: Individual Patient Data Meta-Analysis of Randomized Trials. Stroke 47(3):798–806PubMedPubMedCentralGoogle Scholar
  56. 56.
    Yub Lee S, Won Youn S, Kyun Kim H, Rok DY (2015) Inadvertent detachment of a retrievable intracranial stent: review of manufacturer and user facility device experience. Neuroradiol J 28(2):172–176CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Broderick JP, Schroth G (2013) What the SWIFT and TREVO II trials tell us about the role of endovascular therapy for acute stroke. Stroke 44(6):1761–1764CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Turk AS, Spiotta A, Frei D, Mocco J, Baxter B, Fiorella D et al (2014) Initial clinical experience with the ADAPT technique: a direct aspiration first pass technique for stroke thrombectomy. J Neurointerv Surg 6(3):231–237CrossRefPubMedGoogle Scholar
  59. 59.
    Turk AS, Frei D, Fiorella D, Mocco J, Baxter B, Siddiqui A et al (2014) ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy. J Neurointerv Surg 6(4):260–264CrossRefPubMedGoogle Scholar
  60. 60.
    Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD et al (2013) Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 368(10):893–903CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z et al (2013) A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 368(10):914–923CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R et al (2013) Endovascular treatment for acute ischemic stroke. N Engl J Med 368(10):904–913CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    von Kummer R, Gerber J (2013) IMS-3, synthesis, and MR Rescue: no disaster, but down to earth. Clin Neuroradiol 23(1):1–3CrossRefGoogle Scholar
  64. 64.
    Jayaraman MV, Grossberg JA, Meisel KM, Shaikhouni A, Silver B (2013) The clinical and radiographic importance of distinguishing partial from near-complete reperfusion following intra-arterial stroke therapy. AJNR Am J Neuroradiol 34(1):135–139CrossRefPubMedGoogle Scholar
  65. 65.
    Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM et al (2014) Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol 13(6):567–574CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Bates S, British Institute of Radiology (2012) Godfrey Hounsfield: intuitive genius of CT, vol xiv. British Institute of Radiology, London, 261ppGoogle Scholar
  67. 67.
    Pincock S (2003) US and UK researchers share Nobel prize. Paul C Lauterbur and Peter Mansfield share award for seminal work on MRI. Lancet 362(9391):1203CrossRefPubMedGoogle Scholar
  68. 68.
    Taylor DG, Bushell MC (1985) The spatial mapping of translational diffusion coefficients by the NMR imaging technique. Phys Med Biol 30(4):345–349CrossRefPubMedGoogle Scholar
  69. 69.
    Smajlovic D, Sinanovic O (2004) Sensitivity of the neuroimaging techniques in ischemic stroke. Med Arh 58(5):282–284PubMedGoogle Scholar
  70. 70.
    Moseley ME, Cohen Y, Mintorovitch J, Chileuitt L, Shimizu H, Kucharczyk J et al (1990) Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med 14(2):330–346CrossRefPubMedGoogle Scholar
  71. 71.
    Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355(9216):1670–1674CrossRefPubMedGoogle Scholar
  72. 72.
    Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME et al (2001) Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 22(8):1534–1542PubMedGoogle Scholar
  73. 73.
    Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT et al (2003) Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 34(8):1925–1931CrossRefPubMedGoogle Scholar
  74. 74.
    Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372(11):1019–1030CrossRefPubMedGoogle Scholar
  75. 75.
    Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285–2295CrossRefPubMedGoogle Scholar
  76. 76.
    Lima FO, Furie KL, Silva GS, Lev MH, Camargo EC, Singhal AB et al (2010) The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion. Stroke 41(10):2316–2322CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Tolosa E (1968) Collateral circulation in occlusive vascular lesions of the brain. The role of the middle meningeal artery in the collateral circulation in compensating for occlusions of the internal carotid artery or its branches. Prog Brain Res 30:247–254CrossRefPubMedGoogle Scholar
  78. 78.
    Elijovich L, Goyal N, Mainali S, Hoit D, Arthur AS, Whitehead M et al (2015) CTA collateral score predicts infarct volume and clinical outcome after endovascular therapy for acute ischemic stroke: a retrospective chart review. J Neurointerv SurgGoogle Scholar
  79. 79.
    Menon BK, d'Esterre CD, Qazi EM, Almekhlafi M, Hahn L, Demchuk AM et al (2015) Multiphase CT Angiography: A New Tool for the Imaging Triage of Patients with Acute Ischemic Stroke. Radiology 275(2):510–520CrossRefPubMedGoogle Scholar
  80. 80.
    Axel L (1980) Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. Radiology 137(3):679–686CrossRefPubMedGoogle Scholar
  81. 81.
    Miles KA, Hayball M, Dixon AK (1991) Colour perfusion imaging: a new application of computed tomography. Lancet 337(8742):643–645CrossRefPubMedGoogle Scholar
  82. 82.
    Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A et al (2008) Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 7(4):299–309CrossRefPubMedGoogle Scholar
  83. 83.
    Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG et al (2012) MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 11(10):860–867CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E et al (2006) Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60(5):508–517CrossRefPubMedGoogle Scholar
  85. 85.
    Lansberg MG, Lee J, Christensen S, Straka M, De Silva DA, Mlynash M et al (2011) RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke 42(6):1608–1614CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    de Lucas EM, Sanchez E, Gutierrez A, Mandly AG, Ruiz E, Florez AF et al (2008) CT protocol for acute stroke: tips and tricks for general radiologists. Radiographics 28(6):1673–1687CrossRefPubMedGoogle Scholar
  87. 87.
    d'Esterre CD, Roversi G, Padroni M, Bernardoni A, Tamborino C, De Vito A et al (2015) CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke. Neurol Sci 36(10):1777–1783CrossRefPubMedGoogle Scholar
  88. 88.
    Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372(1):11–20CrossRefPubMedGoogle Scholar
  89. 89.
    Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372(24):2296–2306CrossRefPubMedGoogle Scholar
  90. 90.
    Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372(11):1009–1018CrossRefPubMedGoogle Scholar
  91. 91.
    Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC et al (2015) 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients with Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 46(10):3020–3035CrossRefPubMedGoogle Scholar
  92. 92.
    Perez de la Ossa N, Carrera D, Gorchs M, Querol M, Millan M, Gomis M et al (2014) Design and validation of a prehospital stroke scale to predict large arterial occlusion: the rapid arterial occlusion evaluation scale. Stroke 45(1):87–91CrossRefPubMedGoogle Scholar
  93. 93.
    Prabhakaran S, O'Neill K, Stein-Spencer L, Walter J, Alberts MJ (2013) Prehospital triage to primary stroke centers and rate of stroke thrombolysis. JAMA Neurol 70(9):1126–1132CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Oregon Health & Science UniversityPortlandUSA

Personalised recommendations